Literature DB >> 8547678

Aorta-associated CD34+ hematopoietic cells in the early human embryo.

M Tavian1, L Coulombel, D Luton, H S Clemente, F Dieterlen-Lièvre, B Péault.   

Abstract

Hematopoiesis is established from circulating blood stem cells that seed the embryonic rudiments of blood-forming tissues, a basic notion in developmental hematology. However, the assumption that these stem cells originate from the extraembryonic mesoderm, where primitive hematopoiesis is initiated by intrinsic precursors, has been reconsidered after analysis of blood cell development in avian embryo chimeras: yolk-sac-derived stem cells do not contribute significantly to the definitive blood system, whose first forerunners develop independently along the ventral aspect of the embryonic aorta. Recently, the homologous intraembryonic tissues of the mouse have been submitted to sensitive in vivo and in vitro assays, which showed that they also harbor multipotential hematopoietic stem cells. We have now identified a dense population of hematogenous cells, marked by the surface expression of the CD34 glycoprotein, associated with the ventral endothelium of the aorta in the 5-week human embryo. Therefore, we extend to the human species the growing evidence that intraembryonic hematopoietic cells developing independently of the yolk sac might be the real stem of the whole blood system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8547678

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  83 in total

1.  Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo.

Authors:  M F de Bruijn; N A Speck; M C Peeters; E Dzierzak
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 2.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function.

Authors:  Silviu Itescu; Alfred A Kocher; Michael D Schuster
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

4.  Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.

Authors:  Tea Soon Park; Ludovic Zimmerlin; Elias T Zambidis
Journal:  Cytometry A       Date:  2012-06-26       Impact factor: 4.355

5.  Three-dimensional cartography of hematopoietic clusters in the vasculature of whole mouse embryos.

Authors:  Tomomasa Yokomizo; Elaine Dzierzak
Journal:  Development       Date:  2010-09-28       Impact factor: 6.868

6.  Single-cell resolution of morphological changes in hemogenic endothelium.

Authors:  Frank L Bos; John S Hawkins; Ann C Zovein
Journal:  Development       Date:  2015-08-01       Impact factor: 6.868

7.  ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.

Authors:  Neha Singh; Shrinidh Joshi; Lirong Guo; Matthew B Baker; Yan Li; Ronald K Castellano; Mohan K Raizada; Yagna P R Jarajapu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

8.  The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.

Authors:  Alicia Bárcena; Mirhan Kapidzic; Marcus O Muench; Matthew Gormley; Marvin A Scott; Jingly F Weier; Christy Ferlatte; Susan J Fisher
Journal:  Dev Biol       Date:  2008-12-03       Impact factor: 3.582

Review 9.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

10.  The discovery of a source of adult hematopoietic cells in the embryo.

Authors:  Elaine Dzierzak; Alexander Medvinsky
Journal:  Development       Date:  2008-08       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.